APAC In-Vitro Toxicology Testing Market - Industry Trends and Forecast to 2030

APAC In-Vitro Toxicology Testing Market - Industry Trends and Forecast to 2030

The Asia-Pacific in-vitro toxicology testing market is expected to reach USD 6,467.46 Million by 2030 from USD 2,876.59 Million in 2022, growing at a CAGR of 10.7% during the forecast period of 2023 to 2030.

Market Segmentation

Asia-Pacific In-Vitro Toxicology Testing Market, By Product and Service (Consumables, Services, Assays, Equipments, and Software), Toxicology End Point and Test (Adme (Absorption, Distribution, Metabolism, & Excretion) Testing, Cytotoxicity Testing, Genotoxicity Testing, Dermal Toxicity Testing, Ocular Toxicity Testing, Organ Toxicity Testing, Skin Irritation, Corrosion, & Sensitization Testing, Phototoxicity Testing, and Other Toxicity Endpoints & Tests), Technology (Cell Culture Technologies, High-Throughput Technologies, Molecular Imaging, and Omics Technology), Method (Cellular Assays, Biochemical Assays, Ex-Vivo Models, and In Silico Models), Industry (Pharmaceutical & Biopharmaceutical Companies, Diagnostics, Food, Chemicals, Cosmetics & Household Products), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (China, Japan, India, Australia, New Zealand, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Taiwan, and Rest of Asia-Pacific) - Industry Trends and Forecast to 2030

Overview of Asia-Pacific In-Vitro Toxicology Testing Market Dynamics:

Driver

• Strategic initiatives by major market players

Restrain

• Need for skilled personnel and infrastructure
Opportunity

• Rapidly growing pharmaceutical and medical device industries

Market Players
Some of the major market players operating in the Asia-Pacific in-vitro toxicology testing market are:
• BioIVT
• Creative Biolabs
• Aragen Life Sciences Ltd.
• Shanghai Medicilon Inc.
• Creative Bioarray
• InSphero
• IONTOX
• Preferred Cell Systems
• AAT Bioquest, Inc.